Treatment for Bacterial Vaginosis and Chlamydia Co-infection
Treat both infections concurrently: azithromycin 1g orally as a single dose for chlamydia PLUS metronidazole 500mg orally twice daily for 7 days for bacterial vaginosis.
Chlamydia Treatment
For the chlamydia infection, the recommended regimens are equally efficacious 1, 2:
- Azithromycin 1g orally in a single dose (preferred for compliance)
- OR Doxycycline 100mg orally twice daily for 7 days
I strongly recommend azithromycin for this patient because it provides single-dose directly observed therapy, eliminating compliance concerns 1, 3. Meta-analysis demonstrates equal efficacy between azithromycin and doxycycline (97% vs 98% cure rates) 2. While doxycycline costs less, azithromycin's single-dose administration is particularly valuable in real-world practice where adherence to 7-day regimens may be suboptimal.
Alternative regimens if azithromycin/doxycycline cannot be used 1:
- Levofloxacin 500mg orally once daily for 7 days
- Ofloxacin 300mg orally twice daily for 7 days
- Erythromycin base 500mg orally four times daily for 7 days (less efficacious, more GI side effects)
Bacterial Vaginosis Treatment
For symptomatic BV, the recommended regimen is 3:
- Metronidazole 500mg orally twice daily for 7 days (preferred)
Alternative regimens 3:
- Clindamycin cream 2%, one full applicator (5g) intravaginally at bedtime for 7 days
- Metronidazole gel 0.75%, one full applicator (5g) intravaginally twice daily for 5 days
- Metronidazole 2g orally single dose (lower efficacy, ~84% vs 95% for 7-day regimen) 4
- Clindamycin 300mg orally twice daily for 7 days
The 7-day oral metronidazole regimen achieves 95% cure rates and is superior to the single-dose regimen 4. Intravaginal options avoid systemic side effects but oral therapy remains the gold standard.
Critical Management Points
Alcohol avoidance: Instruct the patient to avoid alcohol during metronidazole treatment and for 24 hours after completion 4, 3.
Sexual abstinence: The patient must abstain from sexual intercourse for 7 days after completing azithromycin OR until completing the full 7-day doxycycline course 1, 3. This prevents transmission and reinfection.
Partner management: All sexual partners from the past 60 days require evaluation and treatment for chlamydia 1, 3. Partners should be treated even if asymptomatic. For BV, treating male partners is NOT beneficial and not recommended 4.
Dispensing strategy: Dispense medications on-site and directly observe the first dose of azithromycin to maximize compliance 1.
Follow-up and Rescreening
No test-of-cure needed for chlamydia after azithromycin unless symptoms persist or reinfection is suspected 1. Testing before 3 weeks post-treatment may yield false-positives from dead organisms 2.
Rescreen for chlamydia in 3 months - this is critical. Women treated for chlamydia have high reinfection rates (often from untreated partners or new partners), and repeat infections increase PID risk 1, 2. Rescreen whenever she returns for care within 3-12 months 2.
BV follow-up: Only needed if symptoms persist 4. BV recurrence is common (50-80% within 12 months) 5, 6. Recent research suggests metronidazole treatment that resolves BV may also reduce chlamydia burden 7, though this requires further study.
Important Caveats
Co-infection considerations: The association between BV and chlamydia is well-documented 8, 7. BV-associated bacteria may facilitate chlamydia persistence, and treating BV may aid in chlamydia clearance 7.
Screen for other STIs: Given chlamydia diagnosis, test for gonorrhea, HIV, and syphilis. Consider trichomoniasis testing as well 1.
Pregnancy status: Confirm she is not pregnant. If pregnant, doxycycline and fluoroquinolones are contraindicated; use azithromycin for chlamydia and adjust BV treatment accordingly 4.